Zacks Investment Research on MSN
Will Ion Platform's 52% Growth Make It ISRG's Next Growth Engine?
Intuitive Surgical’s ISRG third-quarter performance highlights a pivotal shift in its platform mix, with robotic bronchoscopy ...
Background Bronchoscopic limitations in reaching peripheral pulmonary lesions (PPLs) can compromise biopsy sensitivity, ...
A new technology is evolving lung cancer detection and treatment at Ascension Sacred Heart Bay. It’s called the ‘Ion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback